BioSpace News Archive

Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, will present updated exposure-response analyses from the Phase 1b platinum-resistant ovarian cancer and Phase 1b clear cell renal cancer trials at the American Association for Cancer Research (AACR) annual meeting taking place between April 8-13, 2022 in New Orleans, Louisiana.

Evotec SE presents at its virtual Capital Markets Day how artificial intelligence and machine learning enabled precision technologies in discovery and development processes are driving up Probability of Success, i.e. an increasing rate of approvals in the long-run.

Prokarium announced it exercised its option with Lausanne University Hospital for an exclusive, worldwide license for the use of Salmonella immunotherapy in the treatment of bladder cancer.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Raymond James 43rd Annual Institutional Investors Conference at 11:15 a.m. PT (2:15 p.m. ET) on Tuesday, March 8, 2022.

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the 42nd Annual Cowen Healthcare Conference being held virtually on Wednesday, March 9.

Yield10 Bioscience, Inc. today announced that the Company will report its fourth quarter and full year 2021 financial results and provide a corporate update on Wednesday, March 9, 2022.

Creative Medical Technology Holdings, Inc. announced the appointment of Sahil Nock as the Company’s Chief Commercial Officer, effective February 28, 2022.

Simulations Plus, Inc today announced that management will be presenting at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference, scheduled for March 6-9, 2022, at the JW Marriott Grande Lakes in Orlando, Florida.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in the Microsoft® PowerPoint® application with one click.

Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International.